new_0222_0299|ALGS|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_0222_0299|ALGS|1|Aligos Therapeutics Inc Total Current Assets (Quarterly) (USD)|Aligos Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Aligos Therapeutics Inc Inventories (Quarterly) (USD)|Aligos Therapeutics Inc Net PP&E (Quarterly) (USD)|Aligos Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Aligos Therapeutics Inc Total Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Aligos Therapeutics Inc Total Deposits (Quarterly) (USD)|Aligos Therapeutics Inc Book Value (Quarterly) (USD)|Aligos Therapeutics Inc Retained Earnings (Quarterly) (USD)|Aligos Therapeutics Inc Treasury Stock (Quarterly) (USD)|Aligos Therapeutics Inc EV to Revenues|Aligos Therapeutics Inc EV to Earnings|Aligos Therapeutics Inc EV to Free Cash Flow|Aligos Therapeutics Inc EV to Assets (Quarterly)|Aligos Therapeutics Inc PS Ratio|Aligos Therapeutics Inc PE Ratio|Aligos Therapeutics Inc Price to Book Value|Aligos Therapeutics Inc PEG Ratio|Aligos Therapeutics Inc Debt to Equity Ratio|Aligos Therapeutics Inc Dividend Yield|Aligos Therapeutics Inc Shareholder Yield (TTM)|Aligos Therapeutics Inc Percent of Shares Outstanding Short|Aligos Therapeutics Inc Total Receivables (Quarterly) (USD)|Aligos Therapeutics Inc Total Payables (Quarterly) (USD)|Aligos Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Aligos Therapeutics Inc Return on Invested Capital|Aligos Therapeutics Inc Quality Ratio Score|Aligos Therapeutics Inc Momentum Score|Aligos Therapeutics Inc Beta (1Y)|Aligos Therapeutics Inc Sustainable Growth Rate (TTM)|Aligos Therapeutics Inc Institutional Investor Ownership Percentage|Aligos Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Aligos Therapeutics Inc Total Employees (Annual)|Aligos Therapeutics Inc EPS Diluted (Quarterly) (USD)|Aligos Therapeutics Inc Shares Outstanding|Aligos Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Aligos Therapeutics Inc Ordinary Shares Number (Quarterly)|Aligos Therapeutics Inc Payout Ratio|Aligos Therapeutics Inc Quick Ratio (Quarterly)|Aligos Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Aligos Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Aligos Therapeutics Inc Effective Tax Rate (TTM)|Aligos Therapeutics Inc Return on Equity|Aligos Therapeutics Inc Net Income (TTM) (USD)|Aligos Therapeutics Inc Revenue (TTM) (USD)|Aligos Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Aligos Therapeutics Inc Revenue (Quarterly) (USD)|Aligos Therapeutics Inc Gross Profit (Quarterly) (USD)|Aligos Therapeutics Inc SG&A Expense (Quarterly) (USD)|Aligos Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Aligos Therapeutics Inc Net Income (Quarterly) (USD)|Aligos Therapeutics Inc Net Interest Income (Quarterly) (USD)|Aligos Therapeutics Inc Price (USD)|Aligos Therapeutics Inc Total Return Price (USD)|Aligos Therapeutics Inc Enterprise Value (USD)|Aligos Therapeutics Inc 30-Day Average Daily Volume|Aligos Therapeutics Inc 1 Year Price Returns (Daily)||
new_0222_0299|ALGS|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_0222_0299|ALGS|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_0222_0299|ALGS|5|106.5|106.5|0|106.5|0|106.5|106.5|106.5|0|106.5|106.5|0|0|0|1.44912280702|91.5|0|0|1.44755244755|0|91.5|1.45103857567|0|15.2666666667|0|106.5|106.5|0|0|31|30.6666666667|0|30.4444444444|91.375|91.4|91.375|29.8461538462|91.3333333333|106.5|0|91.5|91.375|91.25|91.4|0|91.4|0|0|91.5|0|91.375|91.375|91.375|91.375|1.44970414201|1.44970414201|1.45103857567|1.4512987013|1.43529411765||
new_0222_0299|ALGS|6|6|6|0|6|0|6|6|6|0|6|6|0|0|0|285|2|0|0|286|0|2|337|0|30|0|6|6|0|0|2|3|0|9|8|5|8|13|6|6|0|2|8|4|5|0|5|0|0|2|0|8|8|8|8|338|338|337|308|85||
new_0222_0299|ALGS|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_0222_0299|ALGS|201909||||||||||||||||||||||||||||||||||21.9313||-16.0171||||||-0.6407|||||||||2.775|-14.051|-14.051|0.345|||||||
new_0222_0299|ALGS|201912|120.226|117.663||16.087||211.411|13.818|197.593||-64.891|-66.197|||||||||||||||3.767|0|||||||21.9313||-20.7284|||36.8902|||-0.8291|||||||||3.463|-18.099|-18.184|0.556|||||||
new_0222_0299|ALGS|202003||||||||||||||||||||||||||||||||||21.9313||-22.8316||-0.405||||-0.9133|||||||||3.419|-20.029|-20.029|0.468|||||||
new_0222_0299|ALGS|202006|132.229|128.897||16.212||26.718|15.364|11.354||121.958|-107.023|||||||||||||||3.296|0.002|||||||21.9313|67|-23.707||0|36.8902|||-0.9483||-0.0356||-73.061|||||4.095|-20.856|-20.797|0.374|||||||
new_0222_0299|ALGS|202009|73.693|70.064||15.646||228.851|19.984|208.867||-136.668|-140.32|||||||||||0||5.2978||7.682|0||||||19.4208|36.8902|73|-22.565|1.4756|0|36.8902|||-0.9026|0|-0.0282||-92.307|||||4.225|-33.297|-33.297|0.234|369.5|369.5|475.1702|11035.9||454|
new_0222_0299|ALGS|202012|250.017|243.513||14.908||45.263|30.274|14.989||220.039|-174.74||||-10.0705||||4.5998|||0||5.3504||3.313|0.004|||||||36.6062|74|-27.25|1.4642|0.405|36.6062|||-1.09|-155.542|-0.1476||-108.543|||||6.205|-34.201|-34.42||715|715|920.6098|10423.3333||664.25|645.75
new_0222_0299|ALGS|202103|219.826|213.415||14.526||39.32|25.231|14.089||195.22|-202.414||||-7.6928|2.7887|||3.4946||0|0||4.0591||2.81|0.004|||||||37.4343|69|-18.5|1.5259|0|38.1472||8.4584|-0.74||-0.1768||-116.188|||0.91||5.781|-27.629|-27.674|0.105|568.5|568.5|654.0592|2396.4667||633.25|728.75
new_0222_0299|ALGS|202106|196.642|190.653||13.753||42.992|30.098|12.894||168.884|-232.232||||-6.5392|2.7755|||5.2357||0|0||4.4728||1.593|0.004||||||95.7986|37.619|86|-19.75|1.528|0|38.2001||6.3344|-0.79||-0.2338||-125.209|||1.545||6.556|-29.79|-29.818|0.072|509.625|509.625|588.054|6678.4667||388.5|403.25
new_0222_0299|ALGS|202109|248.67|242.185||13.158||46.057|34.78|11.277||217.011|-265.358||||-4.2517|1.5917|||3.9662||0|0||4.4608||2.601|0.004|||4|1.9573|||42.4|86|-19.5|1.7045|0|42.6118||6.9633|-0.78|-78.584|-0.3354||-125.036|||1.537||6.473|-32.998|-33.124|0.02|379|379|455.3146|9699.7|7.7808|405|407.5
new_0222_0299|ALGS|202112||190.734||||50.638|||||||||-2.6773||108.5303||2.4272|||0||5.2997||||||3|0.1472|||||-22.25|1.7076|||||||||-128.33|4.359||0.367||9.717||-37.714||301.25|301.25|271.3258|7949.1|-57.0705|71|55.25
new_0222_0299|ALGS|202203||183.222||||57.584|||||||||||19.5208||0.4934|||||||||||||||||-21|1.7078|||||||||-136.271|6.02||2.571||6.452||-35.615||52|52|-101.9284|13522||31.5|29.75
new_0222_0299|ALGS|202206||159.344||||45.542|||||||||||8.9491||0.3658|||||||||||||||||-11.75|1.7123|||||||||-126.377|8.168||3.693||7.576||-19.924||31.75|31.75|-127.2916|14378.5667||32.25|31.25
new_0222_0299|ALGS|202209||142.304||||42.056|||||||||||5.5007||0.3313|||||||||||||||||-11|1.7126|||||||||-111.874|10.737||4.106||5.263||-18.621||27.5|27.5|-95.2075|3137.0667||26.5|25
new_0222_0299|ALGS|202212||125.827||||42.793|||||||||||3.7979||0.3369|||||||||||||||||-12.75|1.7169|||||||||-96.046|13.907||3.537||7.119||-21.886||22.4975|22.4975|-101.5056|6036.3||47|41.25
new_0222_0299|ALGS|202303||103.516||||36.988|||||||||||3.4077||0.4587|||||||||||||||||-13.25|1.7176|||||||||-83.386|14.059||2.723||8.506||-22.955||27.875|27.875|-65.9864|4067.3333||25.875|28.25
new_0222_0299|ALGS|202306||90.838||||36.495|||||||||||2.7699||0.4611|||||||||||||||||-10.75|1.7401|||||||||-82.253|17.252||6.886||9.246||-18.791||23.15|23.15|-64.4406|6634.9333||22.6125|21.88
new_0222_0299|ALGS|202309||70.429||||31.031|||||||||||1.7673||0.4437|||||||||||||||||-10.37|1.7401|||||||||-81.673|16.385||3.239||6.443||-18.041||17.755|17.755|-59.9425|1794.5||15.365|17.275
new_0222_0299|ALGS|202312||135.704||||59.447|||||||||||1.9419||1.0093|||||||||||||||||-9.2853|3.0039|||||||||-87.679|15.529||2.681||6.421||-27.892||18.46|18.46|-15.0988|13252.7667||17.25|24
new_0222_0299|ALGS|202403||112.739||||68.106|||||||||||3.3617||0.8045|||||||||||||||||-5.58|3.1504|||||||||-99.587|13.792||0.986||6.666||-34.863||24.475|24.475|-61.6255|22377.8667||20.725|15.25
new_0222_0299|ALGS|202406||94.536||||41.582|||||||||||2.3227||0.4943|||||||||||||||||0.75|3.1914|||||||||-75.735|7.967||1.061||6.376||5.061||9.46|9.46|-83.1822|13166.0667||13.4975|12.68
new_0222_0299|ALGS|202409||74.922||||38.33|||||||||||4.413||0.3822|||||||||||||||||-3.07|3.3248|||||||||-76.953|5.997||1.269||4.626||-19.259||8.04|8.04|-68.8394|101305.4||8.4|25.51
new_0222_0299|ALGS|202412||56.939||||99.067|||||||||||63.2861||2.9472|||||||||||||||||-13.08|3.8644|||||||||-131.211|3.945||0.629||5.161||-82.15||41.15|41.15|72.7201|478491.8||25.8|16.87
new_0222_0299|ALGS|202503||137.861||||34.254|||||||||||17.0765||0.4332|||||||||||||||||-2.11|6.1148||||||-101.742|||-53.26|3.27||0.311||5.052||43.088||9.12|9.12|-1.1766|201735.1667||5.83|5.735
new_0222_0299|ALGS|202506|||||||||||||||||17.3432||0.3786||||||||||||||||||||||||||||||||||||7.21|7.21|-87.475|153061||7.84|